Arnaud Tiberghien
Bicycle Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Synthesis and pharmacology of benzodiazepine derivatives, Cancer therapeutics and mechanisms, HER2/EGFR in Cancer Research, Protein Degradation and Inhibitors, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology(2013)243 cited
- → ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies(2018)175 cited
- → Design and Synthesis of Tesirine, a Clinical Antibody–Drug Conjugate Pyrrolobenzodiazepine Dimer Payload(2016)162 cited
- → Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry(2015)138 cited
- → ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer–Containing Antibody–Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies(2016)125 cited
- → Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine(2018)124 cited
- → SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads(2018)83 cited
- → Design, Synthesis, and Biophysical and Biological Evaluation of a Series of Pyrrolobenzodiazepine−Poly(N-methylpyrrole) Conjugates(2006)79 cited
- → SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity(2010)59 cited
- → Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug Conjugates(2017)46 cited